GVK Biosciences

GVK Bioscience’s Ahmedabad clinical pharmacology unit clears FDA audit

Monday, July 30, 2012 09:52 AM

GVK Biosciences, an Asian CRO, announced that its Ahmedabad Clinical Pharmacology Unit has successfully cleared an FDA audit with zero 483s/observations from the agency. FDA visited and audited a First-to-File study for one of GVK BIO’s customers.

More... »


GVK partners with Gates Foundation

Monday, May 16, 2011 12:44 PM

India-based CRO GVK Biosciences has been named as a preferred provider by a consortium, Product Development Partners (PDP), which is focused on drugs for neglected diseases.

More... »


ResearchPoint Global Continues to Grow, Add CRO Partners

Monday, February 22, 2010 07:36 AM

ResearchPoint recently added India-based GVK Biosciences to its ResearchPoint Global network, increasing the number of affiliate contract research organizations (CROs) that work with the organization to nine.

More... »

GVK Biosciences Partners with Excel PharmaStudies in China

Thursday, April 16, 2009 08:04 AM

India-based contract research organization (CRO) GVK Biosciences formed a strategic alliance with Excel PharmaStudies, a CRO in China, to offer clinical trial services across India and China.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs